Current human evidence from large-scale studies has not established a clear or direct link between GLP-1 medications and thyroid cancer in humans
Mass spectra were measured in linear positive mode, using an AutoflexSpeed MALDI mass spectrometer (Bruker Daltonics)
Tracking Progress Beyond the Scale While weight loss often serves as the primary metric, ColonBroom GLP-1 Booster users benefit from tracking multiple indicators of success: Waist circumference measurements (often more indicative of belly fat loss than scale weight) Energy levels throughout the day Sleep quality improvements Digestive comfort and regularity Mood stability and reduced cravings Blood sugar stability (for those monitoring) These diverse metrics provide a comprehensive picture of health improvements and maintain motivation during inevitable weight loss plateaus
They do not provide medical oversight
Anxiety and Stress Reduction A 2023 randomized clinical trial published in the highly respected *Journal of Psychiatric Research* provided compelling evidence that ALCAR supplementation significantly reduced both the somatic (physical) and psychological symptoms associated with chronic anxiety compared to the inert placebo
Aguirre GA, De Ita JR, de la Garza RG, Castilla-Cortazar I
